Funding opportunities
2,858 live opportunities from Grants.gov, NIH, NSF, and more.
AI & Machine LearningAgriculture & Food ScienceBiomedical & HealthBiology & Life SciencesChemistry & MaterialsClimate & EnvironmentCybersecurity & ITDefense & SecurityEconomics & BusinessEducation & WorkforceEnergy & SustainabilityEngineeringHumanities & ArtsInfrastructure & TransportationMathematics & StatisticsPhysics & AstronomyPublic HealthSmall Business (SBIR/STTR)Social Sciences & PolicySpace & AerospaceVeterinary & Animal ScienceWater & Oceans
- Role of CXCR6+ T-cells in ICI myocarditisNational Heart Lung and Blood InstitutePA-24-182 closes 5/31/2031up to $163,188activenih
- Facilitating Accelerated Science and Translation for TB Regimen Development (FAST-TB)National Institute of Allergy and Infectious DiseasesPAR-23-065 closes 5/31/2031up to $3,499,366activenih
- Targeting PTPN22 for Novel Cancer Immunotherapeutic AgentsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $593,249activenih
- Identifying Biobehavioral Predictors and Targeting Mechanisms of Intervention in Adolescent Posttraumatic Stress DisorderNational Institute of Mental HealthPA-24-184 closes 5/31/2031up to $206,547activenih
- Quantitative Multiparametric PSMA PET MR to Optimize Treatment Planning for Partial Gland Ablation of Prostate CancerNational Cancer InstitutePAR-25-081 closes 5/31/2031up to $709,677activenih
- Mechanisms of Invariant Natural Killer T Cell Regulation of Food-Specific IgENational Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $188,005activenih
- PARSEC: Plasmodium falciparum Adaptive Response to Sickle trait ErythrocytesNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $788,379activenih
- Signal relay during directed cell migration and inflammation in skinNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $690,883activenih
- Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade gliomaNational Cancer InstitutePA-25-301 closes 5/31/2031up to $721,653activenih
- Optimization of a novel and effective antiviral agent targeting Zika NS4BNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $139,920activenih
- Atypical Sphingolipids in healthy and diseased liverNational Cancer InstitutePA-25-301 closes 5/31/2031up to $634,062activenih
- Coordinating Central Tolerance: Defining Distinct Roles for Nr4a1 and Nr4a3 in Thymocyte SelectionNational Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $201,744activenih
- Neural Substrates of Perseverative Thought Disengagement and Reward Learning in Early Adolescence: The Role of Puberty and Implications for Internalizing SymptomsNational Institute of Mental HealthPA-24-186 closes 5/31/2031up to $190,188activenih
- Identification of attenuating mutations in the envelope protein for the rational design of a candidate West Nile live-attenuated vaccine.National Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $420,921activenih
- Next Generation Metabolic Signatures of Infectious Causes of Vaginitis: Small Molecule Metabolite-Based Biomarkers for Diagnosis, Test-of-Cure, and Prediction of RecurrenceNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $867,869activenih
- Regulation of Naive Follicular B Cell PolyreactivityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $778,143activenih
- Naturally Occurring Canine Hemangiosarcoma as a Translational Model for AngiosarcomaNational Cancer InstitutePAR-24-306 closes 5/31/2031up to $635,324activenih
- A Novel Multimodal Approach to Promote Motor Recovery and Plasticity after StrokeEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-305 closes 5/31/2031up to $667,666activenih
- Phage Predation as a Determinant of Diarrheal Disease Severity and Antimicrobial Resistance EmergenceNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $750,263activenih
- Uncovering determinants of pathogenic outcome versus protective responses in filovirus infectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $817,498activenih
- Advancing NEMO’s specific MRI detection of residual breast cancer using novel imaging platformsNational Cancer InstitutePA-25-301 closes 5/31/2031up to $484,944activenih
- Spatial control of synthetic immunogenic cytotoxicity for the treatment of locally advanced lung cancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $682,140activenih
- Estimating and understanding implications of population susceptibility to coccidioidomycosis, an emerging infectious diseaseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $677,822activenih
- Leveraging Multimodal Signatures to Personalize Rectal Cancer Radiotherapy ChoiceNational Cancer InstitutePA-25-301 closes 5/31/2031up to $518,451activenih
- Reducing ReADmissions through Innovative ApplicatioNs of Telemedicine (RADIANT)National Cancer InstitutePAR-25-167 closes 5/31/2031up to $747,660activenih